Instituto de Assistencia Medica ao Servidor Publico Estadual, Sao Paulo Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2016
NCT02878837
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Instituto de Assistencia Medica ao Servidor Publico Estadual, Sao Paulo

Active Ingredients

Drugs in Phase 4 Trials (2)

dexmedetomidine (precedex) (1 trial)

midazolam (versed) (1 trial)

Drugs in Other Trials (1)

hydrocortisone (solu-cortef) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Persistent Vegetative State (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3